imatinib mesylate has been researched along with Hemangiosarcoma in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bellitti, R; Buonocore, M; Casale, B; Covino, FE; De Rosa, N; Santè, P | 1 |
| Kiesel, H; Müller, AM; Schmitt-Graeff, A; Veelken, H | 1 |
| Baker, LH; Verweij, J | 1 |
| Brasky, J; Ehrenpreis, ED; Shah, DA; Sherid, M; Sifuentes, H | 1 |
2 review(s) available for imatinib mesylate and Hemangiosarcoma
| Article | Year |
|---|---|
Future treatment of soft tissue sarcomas will be driven by histological subtype and molecular aberrations.
Topics: Antibiotics, Antineoplastic; Antineoplastic Agents; Benzamides; Cytotoxins; Dermatofibrosarcoma; Disease Progression; Gastrointestinal Stromal Tumors; Hemangioendothelioma; Hemangiosarcoma; Humans; Imatinib Mesylate; Leiomyosarcoma; Liposarcoma, Myxoid; Piperazines; Pyrimidines; Research Design; Sarcoma; Sarcoma, Synovial; Skin Neoplasms | 2010 |
Clinical and endoscopic features of angiosarcoma of the colon: two case reports and a review of the literature.
Topics: Aged; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Benzamides; Colonic Neoplasms; Endoscopy, Digestive System; Female; Gastrointestinal Hemorrhage; Hemangiosarcoma; Humans; Imatinib Mesylate; Paclitaxel; Piperazines; Pyrimidines; Review Literature as Topic; Treatment Outcome | 2013 |
2 other study(ies) available for imatinib mesylate and Hemangiosarcoma
| Article | Year |
|---|---|
Primary cardiac angiosarcoma in a 25-year-old man: excision, adjuvant chemotherapy, and multikinase inhibitor therapy.
Topics: Adult; Antineoplastic Agents; Benzamides; Biopsy; Cardiac Surgical Procedures; Chemotherapy, Adjuvant; Echocardiography, Transesophageal; Heart Neoplasms; Hemangiosarcoma; Humans; Imatinib Mesylate; Male; Piperazines; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-kit; Pyrimidines; Tomography, X-Ray Computed; Treatment Outcome; Vascular Endothelial Growth Factor A | 2013 |
Dramatic and durable efficacy of imatinib in an advanced angiosarcoma without detectable KIT and PDGFRA mutations.
Topics: Administration, Oral; Antigens, CD34; Benzamides; Hemangiosarcoma; Humans; Imatinib Mesylate; Male; Middle Aged; Mutation; Peritoneal Neoplasms; Piperazines; Platelet Endothelial Cell Adhesion Molecule-1; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-kit; Pyrimidines; Receptor, Platelet-Derived Growth Factor alpha; Sequence Analysis, DNA | 2009 |